Nuzenio

Neurothera

Neurothera news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 9 publisher sources 100/100 entity strength

Latest news

SciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center - TipRanksTipRanks · Thu, 06 Aug 2026 06:21:58 GMT NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:48:44 GMT SciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 12:30:00 GMT Tourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMT SciSparc Announces NeuroThera Labs Achieves Milestone in Quantum-Enabled Clinical Trial Data Analytics Platform - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 12:30:00 GMT SciSparc: Subsidiary NeuroThera Labs' Quantum Platform - GlobeNewswireGlobeNewswire · Fri, 31 Jul 2026 07:00:00 GMT What's Going On With SciSparc Shares On Friday? - BenzingaBenzinga · Fri, 31 Jul 2026 07:00:00 GMT S&P 500 Platform Validates NeuroThera’s Quantum Analytics - Quantum ZeitgeistQuantum Zeitgeist · Fri, 31 Jul 2026 00:45:56 GMT

Timeline

Thu, 06 Aug 2026 06:21:58 GMTSciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center - TipRanks

Wed, 05 Aug 2026 12:48:44 GMTNeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-Its-Kind Treatment for Tourette Syndrome - Yahoo Finance

Wed, 05 Aug 2026 12:30:00 GMTSciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver Quantitative

Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan

Fri, 31 Jul 2026 12:30:00 GMTSciSparc Announces NeuroThera Labs Achieves Milestone in Quantum-Enabled Clinical Trial Data Analytics Platform - Quiver Quantitative

Fri, 31 Jul 2026 07:00:00 GMTSciSparc: Subsidiary NeuroThera Labs' Quantum Platform - GlobeNewswire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

SciSparc5 live mentions Yale Child Study4 live mentions Subsidiary NeuroThera Labs4 live mentions Center3 live mentions Quantum3 live mentions Quantum Platform3 live mentions Advances3 live mentions NeuroThera Launches Phase2 live mentions IIb Tourette Trial2 live mentions First2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neurothera.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.